Dermalux® Voted Energy Treatment of The Year 2017 at Prestigious Aesthetic Awards

Aesthetic Technology Ltd are delighted to announce that Dermalux® has been voted Energy Treatment of the Year 2017 in the prestigious British Aesthetic Awards. This achievement for the international market leader continues a five-year winning streak at the London based awards where the Dermalux was previously voted 'Best New Treatment 2013', and 'Treatment of the Year' in 2014, 2015 and 2016.

Recognition for excellence in medical aesthetics is so important and the Aesthetics Awards acknowledges and rewards practitioners, companies and organisations that endorse best practice, deliver outstanding customer service, demonstrate unprecedented skill and who uphold robust ethics in the field of aesthetic medicine.

'Energy Treatment of the Year' is awarded to the best aesthetic treatment that is able to demonstrate a wide range of indications, good safety and efficacy, optimum duration and tangible benefits over other energy based treatments on the market.

As always competition for Energy Treatment of the Year was very strong and the finalists included Endymed, Alma Accent Prime, Ultherapy, CoolSculpting and Dermapen. Dermalux was carefully selected from the finalists using a combination of Aesthetics reader votes and leading industry professional.

The increase in demand and awareness of LED Phototherapy has continued to make Dermalux a 'must have' treatment with aesthetic clinics, beauty salons and Spas. The proven results, versatility safety profile and unrivalled profitability that Dermalux provides has enabled it to maintain its market leading position for the 5th consecutive year as a results, driven non-invasive treatment choice.

Dermalux founders Huw Anthony and Louise Taylor are incredibly proud and grateful to achieve these accolades for the Dermalux treatment and would like to extend a huge thank you to all Dermalux customers in the UK and across the world for their ongoing support. They are looking forward to an exciting 2018 to continue to develop and move the brand forward.